Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasoactive drugs with restrictive infusion during one-lung ventilation
ChiCTR2400084583Phase 4Not yet recruiting
- Sponsor
- The Third Medical Center of PLA General Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of norepinephrine, phenylephrine and ephedrine in anoxemia (3 arms), sponsored by The Third Medical Center of PLA General Hospital. Primary endpoints: endothelin, cyclooxygenase-2 and 5 more. Planned start May 2024; status: not yet recruiting.
02
Drugs
norepinephrinephenylephrineephedrine
03
Conditions
anoxemia
Beyond the preview
Go deeper on ChiCTR2400084583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084583.